Preclinical Assessment of Naloxone Adequacy to Reverse Polysubstance Use-Induced… · FederalPipeline
Preclinical Assessment of Naloxone Adequacy to Reverse Polysubstance Use-Induced…
Presolicitation from Food and Drug Administration, solicitation 75F40126Q00382. Responses due Sep 10, 2026. NAICS 541714, No Set aside used. Listed on SAM.gov.